However, results showed that the level of MSI1 expression did not always correlate with malignancy: considering the fact that gliomas are highly variable in genetic changes/mutations and cellular origin, it is conceivable that both MSI1-dependent and -independent mechanisms are involved in the regulation of malignancy in glioma. Here, MSI1 is linked to central nervous system cancer.